Medicare Monday: One-size-fits-all treatments are wrong for patients

A new case study looks at one-size-fits-all treatments compared to personalized treatment plans.

Allyson Funk
Allyson FunkApril 25, 2016

Medicare Monday: One-size-fits-all treatments are wrong for patients.

MedMon_Catalyst_Banner.jpgThe government is proposing dramatic changes to Medicare Part B, including possible cuts to physician reimbursement for many innovative treatments based on the government’s decisions about which treatments are most valuable for seniors. Unfortunately, these decisions would be based on average results across broad populations, ignoring individual patient needs.  

As a result, patients who don’t fit the average, like Simon, may have difficulty gaining access to the treatment best for them.  For a patient like Simon, diagnosed with late stage and rapidly advancing colorectal cancer, the specific course of treatment has real implications. Simon’s tumor has a specific genetic variant (wild type KRAS), which means he is more likely to respond to specific targeted treatments. Not all treatments are the same, and for Simon, the specific treatment matters.


Assuming that patients should be treated on an average ignores the needs of individual patients, and Simon’s case study is just one example of how this could happen under the government’s proposal.

Download Simon’s profile as a PDF here, and visit other case studies like Simon at

Learn more at

This website uses cookies and other tracking technologies to optimize performance, preferences, usage, and statistics. By clicking “Accept All”, you consent to store on your device the cookies and other tracking technologies that require consent. You can tailor or change your preferences by clicking “Manage My Cookies”. You can check our privacy policy for more information.